Biotage AB (publ)
BITGF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $385 | $582 | $490 | $504 |
| % Growth | -33.8% | 18.8% | -2.8% | – |
| Cost of Goods Sold | $143 | $222 | $187 | $180 |
| Gross Profit | $242 | $360 | $303 | $324 |
| % Margin | 62.9% | 61.9% | 61.8% | 64.3% |
| R&D Expenses | $43 | $51 | $41 | $45 |
| G&A Expenses | $85 | $72 | $68 | $63 |
| SG&A Expenses | $203 | $202 | $194 | $203 |
| Sales & Mktg Exp. | $118 | $130 | $126 | $140 |
| Other Operating Expenses | $8 | -$68 | $3 | $80 |
| Operating Expenses | $254 | $185 | $238 | $328 |
| Operating Income | -$12 | $175 | $65 | -$4 |
| % Margin | -3.1% | 30.1% | 13.3% | -0.8% |
| Other Income/Exp. Net | $16 | -$17 | -$4 | $72 |
| Pre-Tax Income | $4 | $158 | $61 | $68 |
| Tax Expense | $0 | -$1 | $16 | $20 |
| Net Income | $4 | $159 | $45 | $48 |
| % Margin | 1% | 27.3% | 9.2% | 9.5% |
| EPS | 0.05 | 1.99 | 0.55 | 0.6 |
| % Growth | -97.5% | 261.8% | -8.3% | – |
| EPS Diluted | 0.05 | 1.98 | 0.56 | 0.6 |
| Weighted Avg Shares Out | 80 | 80 | 82 | 80 |
| Weighted Avg Shares Out Dil | 80 | 80 | 80 | 80 |
| Supplemental Information | – | – | – | – |
| Interest Income | $16 | $0 | $0 | $0 |
| Interest Expense | $0 | $17 | $4 | $9 |
| Depreciation & Amortization | $40 | $47 | $46 | $46 |
| EBITDA | $28 | $222 | $111 | $123 |
| % Margin | 7.3% | 38.1% | 22.7% | 24.4% |